Brian A. Leuthner

2017 - Edge Therapeutics

In 2017, Brian A. Leuthner earned a total compensation of $2.5M as President and Chief Executive Officer at Edge Therapeutics, a 37% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$255,000
Option Awards$1,761,831
Salary$500,000
Other$10,800
Total$2,527,631

Leuthner received $1.8M in option awards, accounting for 70% of the total pay in 2017.

Leuthner also received $255K in non-equity incentive plan, $500K in salary and $10.8K in other compensation.

Rankings

In 2017, Brian A. Leuthner's compensation ranked 4,378th out of 14,666 executives tracked by ExecPay. In other words, Leuthner earned more than 70.1% of executives.

ClassificationRankingPercentile
All
4,378
out of 14,666
70th
Division
Manufacturing
1,539
out of 5,772
73rd
Major group
Chemicals And Allied Products
444
out of 2,075
79th
Industry group
Drugs
340
out of 1,731
80th
Industry
Pharmaceutical Preparations
268
out of 1,333
80th
Source: SEC filing on April 25, 2018.

Leuthner's colleagues

We found four more compensation records of executives who worked with Brian A. Leuthner at Edge Therapeutics in 2017.

2017

Andrew Saik

Edge Therapeutics

Chief Financial Officer

2017

R Macdonald

Edge Therapeutics

Chief Scientific Officer

2017

Herbert Faleck

Edge Therapeutics

Chief Medical Officer

2017

W Middlekauff

Edge Therapeutics

General Counsel

News

In-depth

You may also like